These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32039993)

  • 1. Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan.
    Nishijima T; Inaba Y; Kawasaki Y; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
    AIDS; 2020 May; 34(6):913-921. PubMed ID: 32039993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA).
    Reniers G; Slaymaker E; Nakiyingi-Miiro J; Nyamukapa C; Crampin AC; Herbst K; Urassa M; Otieno F; Gregson S; Sewe M; Michael D; Lutalo T; Hosegood V; Kasamba I; Price A; Nabukalu D; Mclean E; Zaba B;
    AIDS; 2014 Nov; 28 Suppl 4(4):S533-42. PubMed ID: 25406756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006-2020.
    Niu D; Xiao T; Chen Y; Tang H; Chen F; Cai C; Qin Q; Zhao D; Jin Y; Wang S; Hou Y; Lu Z; Yang L; Liu H; Xie D; Zou H; Lyu F
    BMC Infect Dis; 2023 Mar; 23(1):186. PubMed ID: 36991355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992-2018: A Cohort Study.
    Chen Q; Liu J; Fu X; Yang F; Liu Q; Li J; Tan Z; Li J; Lin K; Yan Y; Yang Y; Li Y; Jiang H
    Front Public Health; 2022; 10():851117. PubMed ID: 35875008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.
    Ruffieux Y; Lemsalu L; Aebi-Popp K; Calmy A; Cavassini M; Fux CA; Günthard HF; Marzolini C; Scherrer A; Vernazza P; Keiser O; Egger M;
    J Int AIDS Soc; 2019 Aug; 22(8):e25339. PubMed ID: 31423727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
    ; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
    Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999-2018.
    Pantke A; Kollan C; Gunsenheimer-Bartmeyer B; Jensen BO; Stephan C; Degen O; Schürmann D; Kurth T; Bremer V; Koppe U;
    Infection; 2024 Apr; 52(2):637-648. PubMed ID: 38381307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiretroviral therapy on all-cause mortality among people living with HIV/AIDS in Ghana using Mahalanobis distant metric matching within propensity score caliper analysis: A retrospective cohort study.
    Dwomoh D; Tambaa C; Ayisi Addo S; Wiah E; Abdulai M; Bosomprah S
    PLoS One; 2018; 13(9):e0203461. PubMed ID: 30192892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.
    Allan B; Closson K; Collins AB; Kibel M; Pan S; Cui Z; McLinden T; Parashar S; Lima VD; Chia J; Yip B; Barrios R; Montaner JSG; Hogg RS
    BMJ Open; 2019 Mar; 9(3):e023957. PubMed ID: 30898806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
    Ingle SM; May MT; Gill MJ; Mugavero MJ; Lewden C; Abgrall S; Fätkenheuer G; Reiss P; Saag MS; Manzardo C; Grabar S; Bruyand M; Moore D; Mocroft A; Sterling TR; D'Arminio Monforte A; Hernando V; Teira R; Guest J; Cavassini M; Crane HM; Sterne JA;
    Clin Infect Dis; 2014 Jul; 59(2):287-97. PubMed ID: 24771333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China.
    Zhu Z; Xu Y; Wu S; Li X; Shi H; Dong X; Xu W
    Front Public Health; 2022; 10():989127. PubMed ID: 36339239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada.
    Lima VD; Eyawo O; Ma H; Lourenço L; Chau W; Hogg RS; Montaner JS
    J Int AIDS Soc; 2015; 18(1):20261. PubMed ID: 26449273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality of People Living with HIV in Paris Area from 2011 to 2015.
    Sellier P; Hamet G; Brun A; Ponscarme D; De Castro N; Alexandre G; Rozenbaum W; Molina JM; Abgrall S;
    AIDS Res Hum Retroviruses; 2020 May; 36(5):373-380. PubMed ID: 31565958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008.
    Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Gerstoft J; Obel N
    Infection; 2012 Dec; 40(6):627-34. PubMed ID: 22791407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
    Brady MT; Oleske JM; Williams PL; Elgie C; Mofenson LM; Dankner WM; Van Dyke RB;
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):86-94. PubMed ID: 20035164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and mortality profile among people living with HIV in a cohort in the Northeastern region of Brazil.
    Leite KME; Lima KO; Ximenes RAA; Albuquerque MFM; Miranda-Filho DB; Godoi ETAM; Montarroyos UR; Lacerda HR
    Rev Inst Med Trop Sao Paulo; 2024; 66():e23. PubMed ID: 38656039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden.
    de Coninck Z; Hussain-Alkhateeb L; Bratt G; Ekström AM; Gisslén M; Petzold M; Svedhem V
    AIDS Patient Care STDS; 2018 Aug; 32(8):297-305. PubMed ID: 30067408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
    Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
    Rupasinghe D; Kiertiburanakul S; Kamarulzaman A; Zhang F; Kumarasamy N; Chaiwarith R; Merati TP; Do CD; Khusuwan S; Avihingsanon A; Lee MP; Ly PS; Yunihastuti E; Nguyen KV; Ditangco R; Chan YJ; Pujari S; Ng OT; Choi JY; Sim B; Tanuma J; Sangle S; Ross J; Law M
    HIV Med; 2020 Jul; 21(6):397-402. PubMed ID: 31852025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.